Published in Neuropsychiatr Dis Treat on December 18, 2014
Association of PECAM-1 Gene Polymorphisms with Kawasaki Disease in Chinese Children. Dis Markers (2017) 0.75
Zinc oxide nanoparticle-induced atherosclerotic alterations in vitro and in vivo. Int J Nanomedicine (2017) 0.75
Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 3.83
PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol (2007) 2.46
Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol (2003) 2.30
Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med (2008) 2.22
Course of platelet activation markers after ischemic stroke. Stroke (2002) 2.05
Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J Leukoc Biol (1999) 1.67
Inflammation and immune system interactions in atherosclerosis. Cell Mol Life Sci (2013) 1.35
PECAM-1: conflicts of interest in inflammation. Life Sci (2010) 1.30
Tissue-specific distributions of alternatively spliced human PECAM-1 isoforms. Am J Physiol Heart Circ Physiol (2002) 1.10
Association of adhesion molecule PECAM-1/CD31 polymorphism with susceptibility to cerebral malaria in Thais. Parasitol Int (2001) 1.00
The alleles of PECAM-1. Gene (2006) 1.00
Neutrophil transmigration mediated by the neutrophil-specific antigen CD177 is influenced by the endothelial S536N dimorphism of platelet endothelial cell adhesion molecule-1. J Immunol (2010) 0.98
Cell adhesion molecules as pharmaceutical target in atherosclerosis. Mini Rev Med Chem (2012) 0.94
R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with progression of CHD and CHD events. Atherosclerosis (2004) 0.93
Short report: codon 125 polymorphism of CD31 and susceptibility to malaria. Am J Trop Med Hyg (2001) 0.92
Platelet-endothelial cell adhesion molecule-1 gene polymorphism and its soluble level are associated with ischemic stroke. DNA Cell Biol (2009) 0.91
Expression pattern of alternatively spliced PECAM-1 isoforms in hematopoietic cells and platelets. J Cell Biochem (2002) 0.91
The homozygous combination of Leu125Val and Ser563Asn polymorphisms in the PECAM1 (CD31) gene is associated with early severe coronary heart disease. Hum Mutat (1999) 0.90
Association between platelet endothelial cellular adhesion molecule 1 (PECAM-1/CD31) polymorphisms and acute myocardial infarction: a study in patients from Sicily. Eur J Immunogenet (2004) 0.90
sPECAM-1 in serum and CSF of acute ischaemic stroke patients. Acta Neurol Scand (2002) 0.90
Innate immune system cells in atherosclerosis. Arch Med Res (2013) 0.89
Leucine125Valine (Leu125Val) Gene Polymorphism of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) and Myocardial Infarction in Indian Population. Indian J Clin Biochem (2010) 0.89
PECAM-1 polymorphism affects monocyte adhesion to endothelial cells. Transplantation (2008) 0.86
Association between platelet endothelial cellular adhesion molecule-1 polymorphisms and atherosclerosis: results of a study on patients from northern Italy. Rejuvenation Res (2010) 0.85
Platelet endothelial cell adhesion molecule-1 polymorphism in patients with bronchial asthma. Iran J Allergy Asthma Immunol (2012) 0.82
PECAM-1 dampens cytokine levels during LPS-induced endotoxemia by regulating leukocyte trafficking. Life Sci (2011) 0.82
CD31/PECAM-1 genotyping and haplotype analyses show population diversity. Tissue Antigens (2007) 0.81
Alterations in Circulating Adhesion Molecules in Acute Myocardial Infarction before and after Thrombolysis with Streptokinase. J Cardiovasc Thorac Res (2013) 0.80
The expression of vascular endothelial platelet endothelial cell adhesion molecule-1 is not regulated by IFN-gamma treatment of C6 tumors in vivo. Int J Oncol (2000) 0.78
A case-control proton magnetic resonance spectroscopy study confirms cerebellar dysfunction in benign adult familial myoclonic epilepsy. Neuropsychiatr Dis Treat (2015) 0.76